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doi:10.1016/j.ejvs.2010.08.001Abstract Background: The lipid metabolism of varicose veins (VVs) remains unknown. To
elucidate the pathogenesis of VV, we utilized the novel technique of imaging mass spectrom-
etry (IMS).
Materials and methods: We obtained VV tissues from 10 limbs of 10 VV patients who under-
went great saphenous vein stripping. As control vein samples, we harvested segmental vein
tissues from 6 limbs of 6 patients with peripheral artery occlusive disease who underwent
infra-inguinal bypass with reversed saphenous vein grafting. To identify the localisation of
lipid molecules in the VV tissues, we performed matrix-assisted laser desorption/ionization
IMS (MALDI-IMS). We also performed MS/MS analyses to identify the structure of each mole-
cule.
Results: We obtained mass spectra directly from control vein tissues and VV tissues and found
a unique localisation of lipid molecules in the VV tissues. We localised lysophosphatidylcholine
(LPC) (1-acyl 16:0), phosphatidylcholine (PC) (1-acyl 36:4) and sphingomyelin (SM) (d18:1/16:0)
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658 H. Tanaka et al.Table 1 Clinical information. Va
control vein samples, segmental
underwent bypass surgery with gia
body mass index (BMI) data are ex
using unpaired Student’s t-test. T
Men/Female
Vein graft (Control) 4/2
Varicose vein (VV) 3/7Conclusion: MALDI-IMS revealed the distribution of various lipid molecules in normal veins and
VVs both. Accumulation of LPC (1-acyl 16:0), PC (1-acyl 36:4) and SM (d18:1/16:0) in the VV
tissues suggested that inflammation associated with abnormal lipid metabolism may contribute
to the development of VV.
ª 2010 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Introduction
Primary varicose vein (VV) is a common venous disease,1,2
and various risk factors have been reported for the
same.3e5 Several studies have reported accompanying
hyperlipidaemia in many of the VV patients.6e8 However,
lipid metabolism in local VV tissues is yet to be analysed.
This study aimed to investigate the lipid profile in the local
region of VV tissues.9 To gain insights into exact the path-
ogenesis in VV tissues, we used the novel technique of
matrix-assisted laser desorption/ionization imaging mass
spectrometry (MALDI-IMS)10,11 to analyse the lipid metab-
olism in VV tissues. At present, few methods exist that can
be used for the holistic study of the distribution of lipid
molecules in vein walls. Lipid stainingdsuch as Oil red O
stainingdis available for visualising high accumulation of
lipids; however, this stain by itself cannot assess differ-
ences in the molecular structures of lipids. In this respect,
MALDI-IMS is the only methodology that can clarify the
distribution of lipid molecules at the molecular species
level. MALDI-IMS can distinguish between different lipid
molecular species by simultaneously determining the
differences in the mass-to-charge ratios (m/z).12e14
Furthermore, tandem mass spectrometry (MSn) on tissue
surfaces enables us to identify the molecules in tissues by
providing detailed information on their structures.12,15e17
In this study, we applied IMS to analyse lipid metabolism
in VV tissues.
Materials and Methods
Sample collection
All the procedures used in this study were approved by the
ethical committee of clinical research in Hamamatsu
University School of Medicine. We obtained VV tissues from
10 limbs of 10 patients who underwent great saphenous vein
(GSV) stripping. The clinical information of these patients is
summarized in Table 1. Clinical disease severity was gradedricose vein tissues (VV) were ob
vein tissues were harvested f
nt saphenous vein (GSV) grafts.
pressed as mean SD SD, and dif
here were no significant differe
Age
mean (SD)
Diseased limb
(right limb/
left limb)
Se
(m
73.5  7.1 4/2 17
66.7  14.0 4/6 20according to the standard CEAP classification according to
the recommendations of an International Consensus
Committee on Chronic Venous Disease. Before surgical
treatment, 4 limbs were assigned to class 2 (simple VV), 1
limbs to class 3 (VVwith ankle swelling), 4 limbs to class 4 (VV
with skin changes), and 1 limb to class 5 (VV with healed
ulcer). In order to compare among the clinical phase groups,
the limbs were grouped according to dermatological symp-
toms into the C2,3 and C4,5 groups. As control vein samples,
segmental vein tissues were harvested from 6 limbs of 6
patients with peripheral artery occlusive disease who
underwent infra-inguinal bypass with reversed GSV grafting
(Table 1). Although the levels of serum total cholesterol (TC)
and triglycerides (TG) did not differ significantly between VV
and control patients (Table 1), the distribution of the lipid
molecules in the vein tissue differed considerably between
the two groups. Our data indicates that it is important to
analyse the lipid profile in the affected area in addition to
the serum lipid profile. We analysed two regions, i.e. the
proximal GSV tissue located close to the sapheno-femoral
junction (SFJ), including a terminal valve (Fig. 1a), and the
more distal GSV tissue located in the mid-thigh area,
including a valve. The red square in Fig. 1b highlights the
analysed region mentioned above. Fig. 1c shows a cross-
section of the frozen tissue before IMS was performed, and
this corresponds to the red square in Fig. 1b. All patients
underwent duplex ultrasound scan with a 7.5-MHz trans-
ducer (LOGIC 500; GE Yokogawa Medical, Tokyo, Japan) to
assess the venous haemodynamics. Duplex scanning was
performed in the standing position. An analysis of the venous
systems in the saphenous systems, its junctions, and their
varicose tracts was carried out along with an analysis of the
presence of non-saphenous reflux. ‘Reflux’ was defined as
a flow in a reverse direction to the physiological flow for
a duration greater than 0.5 s after a provocationmanoeuvre.
All VV patients had retrograde flow in the sapheno-femoral
junction and in the GSV in the calf region; however, the
control group patients showed no reflux in the GSV. The
sample tissues were immediately frozen in liquid nitrogen
and stored at 80 C in order to maintain tissue morphologytained from the patients who underwent stripping surgery. For
rom patients with peripheral artery occlusive disease who
Age, serum total cholesterol (TC), serum triglyceride (TG) and
ferences in the means between the two groups were assessed
nces.
rum TC
g/dL)
Serum TG
(mg/dL)
BMI
Mean (SD)
CEAP classification
(C1/C2/C3/C4/C5/C6)
3.0  32.1 69.7  10.8 20.4  2.3
6.5  42.6 84.6  22.6 21.5  1.90 (0/4/1/4/1/0)
Figure 1 Sample collection and analysis region for IMS. a, Intraoperative picture. b, Schema of the VV (varicose vein) tissue. The
red square represents the analysed region, including the terminal valve in the giant saphenous vein (GSV). c, Cross-section of
frozen tissue before performing IMS, corresponding to the red square in Fig. 1b.
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Figure 2 Representative example for molecular species of
lysophosphatidylcholine (LPC), phosphatidylcholine (PC) and
sphingomyelin (SM). a, LPC (1-acyl 16:0); b, SM (d18:1/16:0);
c, PC (1-acyl 34:1).
Imaging Mass Spectrometry of Varicose Vein Tissues 659and minimize molecular degradation until MALDI-IMS anal-
yses were performed.
Imaging mass spectrometry (IMS)
We cut the frozen tissues, including valves, into 8 mm-thick
sections in the direction of the long axis by using a cryostat
(CM1950; Leica, Wetzler, Germany). Fig. 1c shows a cross-
section that includes a terminal valve. Sections were thaw-
mounted onto an indium-tin-oxide (ITO)-coated glass slides
(Bruker Daltonics, Bremen, Germany) and dried at room
temperature. A total of 500 mL of 2,5-dihydroxybenzoic acid
(2,5-DHB) solution (50 mg/mL in 70% methanol/0.1% tri-
fluoroacetic acid) was sprayed to on the sample sections by
using a 0.2-mm nozzle caliber airbrush (Procon Boy FWA
Platinum; Mr. Hobby, Tokyo, Japan). During spraying, a 15-
cm distance was maintained between the nozzle and the
tissue surface. IMS was performed using a MALDI-hybrid
quadrupole time-of-flight mass spectrometer (QSTAR XL;
Applied Biosystems/MDS Sciex, Foster City, CA) equipped
with an orthogonal MALDI source and an Nd:YAG laser at
a repetition rate of 100 Hz. All analyses were performed in
positive-ion mode after an external calibration with human
angiotensin II ([M þ H]þ, m/z 1046.54) and bradykinin
peptide fragment 1e7 ([M þ H]þ, m/z 757.40 Da). MS
spectra were acquired in the mass range of m/z 400e1000.
IMS was carried out with using the software MALDI server
version 4 by defining a region of interest on the tissue slice.
Two-dimensional ion density images were created using the
BioMap software (Novartis, Basel, Switzerland).18,19
Identification of biomolecules
To identify the molecular-related peaks obtained from IMS,
we conducted tandem mass spectrometric (MSn) analyses by
using a MALDI-quadrupole ion trap (QIT)-TOF mass spec-
trometer (AXIMA-QIT; Shimadzu, Kyoto, Japan). Ionization
was performed with using a 337 nm-pulsed N2 laser. The
pulsed argon gas was used for collision-induced dissociation
(CID). Precursor and fragment ions obtained by CID were
ejected from the ion trap and analysed by a reflectron TOF
detector. The conditions of data acquisition (i.e. the laser
power, collision energy, and number of laser irradiations)
were modified in order to obtain efficient mass spectra.
Specific fragment patterns of lysophosphatidylcholine (LPC),
phosphatidylcholine (PC) and sphingomyelin (SM) (Fig. 2)
were also confirmed by previous reports.13,20e23Statistical analysis
All data were expressed as mean and SD. Differences in the
means between the two groups were assessed using paired
Student’s t-test. Significances of differences in the ion
intensity ratio of the valve to the proximal region among
groups were determined by one-way analysis of variance
(ANOVA) followedbyTukey’s test. All statistical analyseswere
performed using StatView 5.0 (SAS Institute, Tokyo, Japan).
Results
The mass spectra obtained from control vein tissues and VV
tissues are shown in Fig. 3. Among them, we identified 9
peaks, namely, m/z 496, 725, 741, 760, 780, 782, 798, 808
and 820, that we estimated to correspond to LPC, PC and
SM (Table 2) according to previous reports by using
IMS.11,13,18e26 The accumulative spectra did not show
Figure 3 Imaging Mass Spectrometry. The accumulated mass spectrum obtained from the sections of the control vein, C2,3 and
C4,5 among VV tissues.
660 H. Tanaka et al.a marked difference among the three groups. With regard
to the spatial distribution of the molecules, however, we
found characteristic distribution patterns of the molecules
around the valvular regions in VV tissues (Fig. 4). Ion images
created by the BioMap software showed that LPC (1-acyl
16:0) was localised around valves in the VV tissues, while
LPC (1-acyl 16:0) was uniformly distributed in the control
tissues (Fig. 4a). The ratio of LPC (1-acyl 16:0) ion intensity
in the valvular area to that in the proximal area of SFJ was
1.09 SD 0.18, 4.26 SD 1.61 and 4.50 SD 1.50 in the control,
C2,3 and C4,5 groups, respectively. In the mid-thigh area,
the ratio of LPC (1-acyl 16:0) ion intensity in the valvular
area to that in the proximal area of the great saphenous
vein was 3.52 SD 1.07 in the C2,3 group and 3.56 SD 0.76 in
the C4,5 group. Similarly, SM (d18:1/C16:0) was mainlyTable 2 Distribution of phospholipid molecules.
m/z Assignment of lipid molecule
496 LPC (1-acyl16:0) þ H
725 Sphingomyelin (d18:1/16:0) þ H
741 Sphingomyelin (d18:1/16:0) þ Na
760 PC (1-acyl 34:1) þ H
780 PC (1-acyl 34:2) þ Na
782 PC (1-acyl 34:1) þ Na
798 PC (1-acyl 34:1) þ K
808 PC (1-acyl 36:2) þ Na
820 PC (1-acyl 36:4) þ Kdistributed around the valves in the VV tissues, but
uniformly distributed in the control tissues. The ratio of SM
ion intensity in the valvular area to that in the proximal
area of SFJ was 1.06 SD 0.18, 2.84 SD 0.40 and 2.50 SD 0.47
in the control, C2,3 and C4,5 groups, respectively (Fig. 4b).
The ratio of SM (d18:1/C16:0) ion intensity in the valvular
area to that in the proximal area in the mid-thigh area was
2.09 SD 0.74 in the C2,3 group and 2.09 SD 0.74 in the C4,5
group (Fig. 4b). Interestingly, the distribution pattern of PC
depended on the type of the PC molecule. PC (1-acyl 34:2)
was ubiquitously distributed among all groups. On the other
hand, PC (1-acyl 36:4) was accumulated around the valves
in the VV tissues, but not in the control tissues. The ratio of
PC (1-acyl 36:4) ion intensity in the valvular area to that in
the proximal area of SFJ was 0.95 SD 0.06, 3.08 SD 1.00 and
2.88 SD 1.07 in the control, C2,3 and C4,5 groups, respec-
tively (Fig. 4b). The ratio of PC (1-acyl 36:4) ion intensity in
the valvular area to that in the proximal area in the mid-
thigh area was 2.22 SD 0.88 in the C2,3 group and 2.43 SD
0.36 in the C4,5 group. Comparing the C2,3 and C4,5
groups, there were no differences in the lipid species
(Fig. 4b). However, other numerous lipid molecules were
noted, which need to be studied in order to clarify the lipid
metabolism in VV tissues.
Discussion
IMS, which is a mass spectrometry method used for two-
dimensional samples, is becoming a popular imaging
Figure 4 Imaging mass spectrometry (IMS) of human VV revealed a characteristic distribution of phospholipid molecules in the
valvular region as compared to that in the control vein tissue. a, IMS and optical images of haematoxylineeosin (HE) staining. Scale
barZ 200 mm b, Ratio of valve (v) to proximal (p) region. Significances of differences in the ion intensity ratio of the valve to the
proximal region among the three groups were determined by one-way analysis of variance followed by Tukey’s test. *P < 0.05
indicates a significant difference.
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alisation of the distribution of various molecules. In this
technique, mass spectra associated with spatial informa-
tion can be simultaneously recorded to obtain the expres-
sion patterns of various molecules in specimens. This new
procedure of mass spectrometry has been used for the
analysis of biological compounds at both tissue and the
single-cell level. Recent imaging mass spectrometry studies
have been conducted on a variety of topics, including bio-
logical15e18,27 and pathological applications.15,16 Recent
studies have reported direct lipid analyses in mammalian
tissues,17,18,28,29 histopathological materials19 and phar-
macokinetics in rat whole body sections.28
These studies have identified the importance of molecular
imaging techniques in understanding the pathophysiology
and/or pathological biochemistry of individual diseases.9
In this study, we report for the first time the use of MALDI-
IMS in the analysis of VV tissues. We found a characteristic
distribution of lipid species (LPC, SM and PC) around the
damaged valvular area in VV tissues. Although the levels of
serum lipid parameters did not differ significantly between
control and VV patients (Table 1), the localisation of lipid
molecules differed considerably between the two groups
(Fig. 3b). Our data indicates that it is important to analyse
the lipid profile in the affected area in addition to the szrum
lipid profile. It is well known that LPC is associated with
inflammation. LPC is a chemotactic factor for macrophages
and lymphocytes, and is known to induce the expression of
both vascular cell adhesion molecule-1 (VCAM-1) and inter-
cellular adhesion molecule-1 (ICAM-1) in endothelial cells.29
Moreover, LPC is capable of lysing cells at high concentra-
tions due to its detergent-like property. The LPC molecule is
wedge-shaped, consisting of a long hydrophobic fatty acyl
chain and a large hydrophilic polar choline head group,which
are attached to a glycerol backbone.30 The amphipathic
nature of LPC endows it a detergent-like property. The
specific localisation of LPC at the valves of VV tissues sug-
gested that the valves might be damaged by LPC-induced
inflammation or the detergent-like property of LPC.
Dysfunction of the valve causes venous reflux, which leads to
VV development.2,31 Our finding is compatible with those of
previous reports, which state that venous valve incompe-
tence is related to inflammation.32,33 Monocytes and
macrophages infiltrate valve leaflets in chronic venous
disease, and such infiltration has been associated with areas
of the endothelium that express ICAM-1. Recent clinical
studies and basic scientific research suggest a role of matrix
metalloproteinases (MMPs) in damaging the endotheliumand
the smooth muscle components of the vein wall. Then, the
injured endothelial cells trigger leucocyte infiltration, acti-
vation and inflammation, which lead to further vein wall
damage.34,35 Although the mechanism that initiates the
inflammation in venous valves is not known, the accumula-
tion of pro-inflammatory lipid molecules around the valvular
region may be involved in the pathogenesis of the tissue
inflammation process and valvular incompetence. Further
studies are needed to clarify the mechanisms of accumula-
tion of the lipidmolecules. Since PC (1-acyl 36:4) is one of the
major substrates of PLA2, LPC accumulation around the
valvular region in VV tissue may reflect its increased
production via phospholipase A2 (PLA2)-catalyzed PC
hydrolysis. Considering the abundance of fatty acids inhuman tissue, the major fatty acid composition of PC (1-acyl
36:4) would be C16:0 (palmitic acid) and C20:4 (arachidonic
acid (AA)). PLA2 produces LPC and free fatty acids by the
hydrolysis of PC. Therefore, AA production may be increased
by the hydrolysis of PC (1-acyl 36:4) at the valves of VV
tissues. AA is a precursor of lipid mediators, such as prosta-
glandins and leukotrienes, which induce chronic inflamma-
tion. Therefore, inflammation triggered by the AA cascade
should be considered as one of the mechanisms involved in
the formation of VV. SM (d18:1/16:0) may also be involved in
such tissue inflammation. Since SM (d18:1/16:0) has been
observed to be localised around valves in VV tissues, it may
also be involved in tissue inflammation. SM is a precursor of
sphingolipid mediators.36 Several studies have suggested
that sphingolipid mediators, including ceramide and
ceramide 1-phosphate, play integral roles in the process of
inflammation. The accumulation of PC (1-acyl 36:4) and SM
(d18:1/16:0) around the valvular region may critically
aggravate tissue inflammation around the valves in VV.
Characteristic lipid distribution was observed uniformly
in each clinical stage, suggesting that lipid molecules-
related inflammation occurs from the early clinical stage of
the disease and continues until the advanced stages.
However, the initiating mechanism of such abnormal lipid
metabolism is yet to be elucidated. Therefore, further
studies are required in order to validate the cascade
described in our hypothesis. Moreover, other unknown
abnormal lipid metabolisms could exist in the disease
development of VV. Since chronic venous insufficiency (CVI)
is caused by multiple factors, multivariate analyses should
be performed to verify the importance of the characteristic
distributions of the lipid molecules in VV tissues. With the
application of MALDI-IMS, further studies on a larger scale
are needed for performing multivariate analyses, which
could determine the role of the accumulation of the lipid
molecules on disease progress in VV tissues.
With regard to the effectiveness of statin administration
in treating CVI, we currently have no information. Because
the serum TC content did not differ statistically between
the control and VV patients, the effectiveness of statins in
lowering systemic TC levels for improving CVI is doubtful.
However, as recently reported,37 statins possess anti-
inflammatory effects which may ameliorate lipid mole-
cules-mediated VV tissue inflammation.
In summary, in this study, we identified the characteristic
localisation of lipid molecules in the human VV wall using
MALDI-IMS. Our data provides the first evidence of the accu-
mulation of lipid molecules, such as LPC (1-acyl 16:0), PC (1-
acyl 36:4) and SM (d18:1/16:0) around the damaged valvular
region,which suggests theassociationof thesemoleculeswith
tissue inflammation and resultant valvular incompetence.
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